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A B S T R A C T   
Background: Extravasation injury (EVI) is common, yet it is always underestimated and underreported. Severity 
varies ranging from thrombophlebitis up to disability. Unrecognised EVI is a potential medicolegal case in 
medicine. 
Case presentation: We experience a 47-year-old lady who developed an unrecognised EVI after being admitted for 
sepsis. The EVI turned out to be a huge and sloughy skin ulcer. A series of wound debridement with vacuum 
dressing were conducted until the wound was able to be closed. 
Discussion: The EVI can be categorised according to Amjad EVI grading and Loth and Eversmann’s EVI classi-
fication. Adult EVI tends to be overlooked, especially during critical care because patients cannot complain upon 
sedation and ventilation. In order to prevent EVI, firstly prevention is better than cure. Secondly, if EVI is rec-
ognised early, infusion should be stopped immediately. Thirdly, analgesia is mandatory. Finally, the plastic team 
needs to be engaged if it is deemed required. 
Conclusion: Prevention and early intervention before the occurrence of progressive tissue damage is the key to 
treatment. Early radical wound debridement and immediate or delayed wound coverage with skin graft or skin 
flap are indicated in full thickness skin necrosis, persistent pain, and chronic ulcer.   
1. Introduction 
Extravasation injury (EVI) is caused by the escape of solution from a 
vessel into the surrounding structure during intravenous infusion [1]. It 
is common with reported cases between 0.1 and 6% in adult intravenous 
therapy [2,3]. Unrecognised EVI can be a medicolegal and lawsuit case 
in medicine [4]. The extent of tissue injury depends on extravasation 
volume, site of cannula, patient factor, and agent osmolarity and toxicity 
[5,6]. Most common places for complicated EVI to occur include the 
forearm, antecubital fossa, dorsum of the hand, and foot due to the lack 
of substantial fat tissue barrier. Not only can it lead to a full thickness 
skin loss, but it can also cause severe damage to the underlying structure 
[2]. We highlight a 47-year-old lady with an unexpected EVI and discuss 
the management of complicated EVI in adults in order to prevent 
disability and dysfunction. This work has been reported in line with the 
SCARE criteria [7]. 
2. Case presentation 
A 47-year-old lady with underlying diabetes mellitus and hyperten-
sion, presented with lethargy and progressive body weakness for 2 
weeks, shortness of breath, and orthopnoea for 3 days. She was admitted 
in the Intensive Care Unit (ICU) and treated as Gullien-Barriere Syn-
drome with AMAN variant and Streptococcus Hemolyticus bacteraemia 
after a couple of investigations. Intravenous immunoglobulin, as well as 
2 courses of antibiotics (ceftazidime and amoxicillin clavulanate, fol-
lowed by meropenem), was administered through a central venous 
catheter. In the second week of ICU admission, she developed an upper 
gastrointestinal bleeding and required inotropic support and endoscopy. 
She developed a rash over the upper trunk after intravenous sedations 
(benzodiazepine, propofol and fentanyl), so blood transfusion was 
given. Subsequently, the allergic reaction resolved after chlorphenir-
amine was given. 
Two days later, we noticed a 6 × 5 cm non-tender bluish blister over 
the right cubital fossa at the previously placed intravenous cannula. The 
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wound was dressed using purilon gel and foam every alternate day. After 
3 weeks, the wound became sloughy and bedside wound debridement 
was done (Fig. 1). The wound measured about 8 × 5 cm with exposed 
subcutaneous fat. It did not heal despite regular dressing; thus, the pa-
tient was referred to the plastic team for further wound management. 
Wound debridement, basilic vein ligation, and vacuum dressing were 
done by the plastic team in the operation theatre (Fig. 2). After 1 cycle of 
vacuum dressing and no organism growth from the tissue culture, 
another wound debridement was performed with a delayed wound 
closure (Fig. 3). Postoperative recovery was complicated with congested 
and swollen tissue, which was treated conservatively by upper limb 
elevation. The oedema subsided eventually and sutures were removed at 
day-14 post operation. The patient was able to move her right upper 
limb in full range of movement and later transferred out of the ICU to the 
neuromedical ward. Later she was discharge and followed up in plastic 
clinic in 2 weeks, then 1 month and 3 months. Her wound was healed 
well and there is no functional disability. 
3. Discussion 
Patients with EVI initially present with symptoms similar to throm-
bophlebitis, such as oedema, pain, and erythema [6]. If symptoms 
persist for more than 24 hours, it is considered a severe EVI, which can 
potentially develop ulceration or even necrosis, which may appear as 
late as weeks later [6]. The worst complications of EVI can result in 
disability, namely contracture, nerve damage, joint stiffness, and tendon 
damage [3]. Therefore, further damage can be prevented if EVI is 
detected earlier [5]. On the other hand, in complicated EVI, early 
aggressive wound debridement is suggested because chronicity of the 
wound will increase morbidity and cause more functional damage [3]. 
Most of the literature focused more on chemotherapy drugs and 
paediatric EVI, but occurrences in adults tend to be overlooked. The 
severity of many EVI cases may have been underestimated; therefore, 
they have been underreported [1,5]. EVI is more difficult to be recog-
nised in ventilated and sedated patients, as patients would be unable to 
complain about the condition to healthcare workers [3]. In our case, the 
severity of EVI was underestimated as it initially exhibited partial 
thickness, before eventually turning into full thickness skin loss. The 
cause of EVI could not be identified as the cannula was removed earlier 
and the patient was on the central venous line during the discovery of 
EVI. The potential medications that may have caused the EVI in this case 
were propofol, dextrose, and packed cells. 
There are 2 types of grading and classification for EVI according to 
Amjad EVI grading and Loth and Eversmann’s EVI classification, 
respectively [4,6]. These two guidelines would help us to identify and 
classify the EVI severity, allowing for the determination of which 
treatment to be administered. Our patient had a grade 4 severe EVI. 
However, the extravasation volume could not be determined and the 
patient could not complain about any pain since she was intubated. 
Generally, the management of EVI can be categorised into (1) preven-
tion; (2) non-pharmacological treatment; (3) pharmacological treat-
ment; and (4) surgery [1,3,4,6]. 
First, prevention is better than cure. Prevention should always be 
practiced by healthcare workers during cannulation and drug adminis-
tration, especially with regard to vesicant or irritant drugs. For cannu-
lation, a good vein should be chosen; cannulation should start from the 
distal to proximal order in the same vein, while joint sites and lower 
limbs should be avoided. Next, before drug administration, the patency 
of cannula should be checked, the intraluminal pressure in the infusion 
pump should be monitored, and the drug should be diluted in a 
compatible solution. If the drug is vesicant or irritant, it should be given 
in a slow rate or a large vein, before any other drug can be given. After 
all, a regular daily monitoring is vital in detecting early EVI to prevent 
progressive tissue damage. 
Second, if EVI is recognised early, infusion should be stopped 
immediately. Extravasated drug should be aspirated, including 3–5ml 
blood followed by reversal agents/antidote according to the extrava-
sated drug. If the extravasated drug is indeterminate, 0.9% normal saline 
Fig. 1. Wound debridement done after 3 weeks dressing of the right cubital 
fossa blister wound; wound was sloughy and the basilic vein was 
exposed (arrow). 
Fig. 2. Vacuum dressing of the right cubital fossa; wound after basilic vein 
ligation; and repeat wound debridement as non-healing wound with regu-
lar dressing. 
Fig. 3. Wound debridement; delayed wound closure was done once the wound 
is clean. 
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or hyaluronidase subcutaneous injection can be given to dilute and 
disperse the drug into surrounding tissues, followed by egression of 
irrigation fluid through several stab incisions in the surrounding skin. 
Squeeze technique can be used in a distal to proximal direction to 
squeeze out the extravasated drug in case the catheter had been 
removed. Many other measures can be done, such as elevation the EVI 
limb to reduce the swelling and promote the lymphatic reabsorption of 
extravasated drug; warm compression for vasoconstrict agent or specific 
drug (phenytoin, vinca alkaloids, and contrast media); cold compression 
for vesicant or irritant drugs for 15–20 minutes, 3–4 times per day for 
the first 48–72 hours after EVI occurrence; area marking or serial digital 
photograph for monitoring; and regular dressing. Conservative man-
agement is preferred until the lesion has evolved for at least 1 week. 
Third, analgesia is important because EVI can be as painful as a burn 
wound. In an infected wound, antibiotics should be used to treat the 
infection. However, prophylactic antibiotic is not recommended. 
Finally, liposuction with/without saline flush out should be done within 
24 hours after high volume EVI. Plastic team referral for early radical 
wound debridement and immediate or delayed wound coverage with 
skin graft or skin flap should be done if full thickness skin necrosis, 
persistent pain, and chronic ulcer occurred. Fasciotomy is indicated in 
EVI patient with compartment syndrome. 
Adult extravasation injury tends to be overlooked, especially during 
critical care because patients cannot complain upon ventilation, physi-
cians focus on more serious morbidity that patients undergo, and dres-
sing covers up the wound. Therefore, healthcare workers should be more 
vigilant, and cannulation sites should be regularly monitored, even on 
previous cannulation sites. The prevention measures, as mentioned in 
table above, should be reinforced in all patient care. 
In conclusion, EVI can lead to significant morbidity and disability in 
the long term. It may easily be underestimated and underreported, 
especially during critical care. Awareness, prevention, and regular 
monitoring are vital for cannulation care. In severe EVI, the wound 
should be monitored regularly. Early radical wound debridement and 
immediate or delayed wound coverage with skin graft or skin flap are 
indicated in full thickness skin necrosis, persistent pain, and chronic 
ulcer. 
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Appendix 
EVI: extravasation injury. 
ICU: intensive care unit. 
References 
[1] S. Al-Benna, C. O’Boyle, J. Holley, Extravasation injuries in adults, ISRN. Dermatol. 
2013 (2013) 856541. 
[2] M. Doornaert, S. Monstrey, N. Roche, Extravasation injuries: current medical and 
surgical treatment, Acta Chir. Belg. 113 (1) (2013) 1–7. 
[3] A. Sarovath, A. Kruavit, Extravasation injury: what is the appropriate management 
of extravasated skin ulcer? Thai J. Surg. 27 (1) (2006), 19-5. 
[4] P.M. Reynolds, R. MacLaren, S.W. Mueller, D.N. Fish, T.H. Kiser, Management of 
extravasation injuries: a focused evaluation of noncytotoxic medications, 
Pharmacotherapy 34 (6) (2014) 617–632. 
[5] G. van der Wal, J.C. Janssen, P.E. Spronk, Extravasation injury by norepinephrine: a 
case report and description of treatment options, Neth. J. Crit. Care. 17 (3) (2013) 
15–17. 
[6] I. Goutos, L.K. Cogswell, H. Giele, Extravasation injuries: a review, J. Hand. Surg. 
Eur. 39 (8) (2014) 808–818. 
[7] R.A. Agha, T. Franchi, C. Sohrabi, G. Mathew, for the Scare Group, The SCARE 2020 
guideline: updating consensus surgical CAse REport (SCARE) guidelines, Int. J. Surg. 
84 (2020) 226–230. 
H.C. Chong et al.                                                                                                                                                                                                                               
